Fig. 5From: A novel stability-indicating chromatographic quantification of the antiparkinsonian drug safinamide in its pharmaceutical formulation employing HPTLC densitometry and ion-pair HPLC–DADDissolution profile of Parkimedine® Tablets in 0.1 N HCl as FDA-dissolution medium using the developed HPLC–DAD methodBack to article page